Athira Pharma ATHA 深 滬
已收盤 07-25 16:00:00 美东时间
0.458
-0.005
-1.10%
華盛通- 最 高0.47
- 今 開0.4569
- 成交量 12.79万股
- 最 低 0.44
- 昨 收 0.4631
- 總市值 1788.14万
- 52周最高 3.67
- 市盈率 靜 --
- 換手率 0.33%
- 52周最低 0.2195
- 委 比 -96.96%
- 總股本 3904.24万
- 歷史最高 34.79
- 量 比 0.38
- 振 幅 6.48%
- 歷史最低 0.2195
- 每 手 1
- 風險率 0.96%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Athena Gold Boosts Visibility with New Marketing Agreements
Athena Gold ( ($TSE:ATHA) ) has provided an update. Athena Gold Corporation has...
07-04 22:07
ATHA Energy Unveils Promising Uranium Discoveries in Angikuni Basin
Atha Energy Corp. ( ($TSE:SASK) ) has provided an announcement. ATHA Energy Cor...
06-24 20:11
ATHA Energy Strengthens Board with Industry Veteran Appointment
An announcement from Atha Energy Corp. ( ($TSE:SASK) ) is now available. ATHA E...
05-14 20:19
Athira Pharma To Present Data From Phase 1 Clinical Trial Of ATH-1105 In Healthy Volunteers At 4Th Annual ALS Drug Development Summit
Data from Phase 1 clinical trial of ATH-1105 in healthy volunteers showed a favorable safety and tolerability profile; dose proportional pharmacokinetics and CNS penetration support continued clinical developmentOn-track
05-13 23:02
Athira Pharma Reports Reduced Losses and Strategic Focus
Athira Pharma, Inc. ( ($ATHA) ) has released its Q1 earnings. Here is a breakdo...
05-10 12:16
Athira Pharma Q1 EPS $(0.23) Up From $(0.69) YoY
Athira Pharma (NASDAQ:ATHA) reported quarterly losses of $(0.23) per share. This is a 66.67 percent increase over losses of $(0.69) per share from the same period last year.
05-10 04:08
Athira Pharma (ATHA) Gets a Hold from JMP Securities
JMP Securities analyst Jason Butler reiterated a Hold rating on Athira Pharma (...
02-28 14:26
Terns Pharmaceuticals appoints new CFO
Terns Pharmaceuticals (NASDAQ:TERN) announced the appointment of Andrew Gengos as chief financial officer, effective immediately. Gengos most recently, served as the chief financial officer of Athira ...
02-25 05:20
Alterity surges after mid-stage trial data for lead asset
Alterity Therapeutics (NASDAQ:ATHA) announced Thursday that its lead candidate, ATH434, slowed clinical progression with a statistically significant impact in a mid-stage trial for patients with multi...
01-30 21:32
Athira Pharma to Pay $4 Million Over Alleged Research Misconduct
Unity Software(U.US) reported fourth-quarter financial results after the market...
01-07 06:58
